Xu B, Yan M, Ma F, Hu X, et al. Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Oncol 2021 Feb 11. pii: S1470-2045(20)30702.
PMID: 33581774